Guangzhou Kingmed Diagnostics Group Co Ltd (603882) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Guangzhou Kingmed Diagnostics Group Co Ltd (603882) has a cash flow conversion efficiency ratio of 0.047x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥327.19 Million ≈ $47.88 Million USD) by net assets (CN¥6.95 Billion ≈ $1.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Guangzhou Kingmed Diagnostics Group Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)
This chart illustrates how Guangzhou Kingmed Diagnostics Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Guangzhou Kingmed Diagnostics Group Co L carry for a breakdown of total debt and financial obligations.
Guangzhou Kingmed Diagnostics Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Guangzhou Kingmed Diagnostics Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ta Liang Technology Co Ltd
TW:3167
|
-0.022x |
|
Alkami Technology Inc
NASDAQ:ALKT
|
0.051x |
|
China Resources Chemical Innovative Materials Co. Ltd.
SHE:301090
|
-0.030x |
|
Burckhardt Compression
SW:BCHN
|
0.100x |
|
First Commonwealth Financial
NYSE:FCF
|
0.032x |
|
Mando Corp
KO:204320
|
0.109x |
|
Imax Corp
NYSE:IMAX
|
0.066x |
|
China Oilfield Services Limited
F:CO9
|
0.027x |
Annual Cash Flow Conversion Efficiency for Guangzhou Kingmed Diagnostics Group Co Ltd (2012–2024)
The table below shows the annual cash flow conversion efficiency of Guangzhou Kingmed Diagnostics Group Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see market value of Guangzhou Kingmed Diagnostics Group Co L.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.48 Billion ≈ $1.09 Billion |
CN¥906.35 Million ≈ $132.63 Million |
0.121x | -15.80% |
| 2023-12-31 | CN¥8.55 Billion ≈ $1.25 Billion |
CN¥1.23 Billion ≈ $180.11 Million |
0.144x | -34.39% |
| 2022-12-31 | CN¥8.87 Billion ≈ $1.30 Billion |
CN¥1.95 Billion ≈ $285.03 Million |
0.219x | -31.44% |
| 2021-12-31 | CN¥6.52 Billion ≈ $954.46 Million |
CN¥2.09 Billion ≈ $305.54 Million |
0.320x | -18.53% |
| 2020-12-31 | CN¥3.88 Billion ≈ $567.27 Million |
CN¥1.52 Billion ≈ $222.88 Million |
0.393x | +38.16% |
| 2019-12-31 | CN¥2.33 Billion ≈ $340.32 Million |
CN¥661.40 Million ≈ $96.78 Million |
0.284x | +5.00% |
| 2018-12-31 | CN¥1.96 Billion ≈ $286.16 Million |
CN¥529.62 Million ≈ $77.50 Million |
0.271x | +66.60% |
| 2017-12-31 | CN¥1.74 Billion ≈ $255.22 Million |
CN¥283.53 Million ≈ $41.49 Million |
0.163x | -36.92% |
| 2016-12-31 | CN¥1.13 Billion ≈ $165.88 Million |
CN¥292.14 Million ≈ $42.75 Million |
0.258x | +12.24% |
| 2015-12-31 | CN¥959.84 Million ≈ $140.46 Million |
CN¥220.39 Million ≈ $32.25 Million |
0.230x | -60.20% |
| 2014-12-31 | CN¥391.72 Million ≈ $57.32 Million |
CN¥225.97 Million ≈ $33.07 Million |
0.577x | +97.31% |
| 2013-12-31 | CN¥258.41 Million ≈ $37.81 Million |
CN¥75.55 Million ≈ $11.06 Million |
0.292x | -32.66% |
| 2012-12-31 | CN¥203.69 Million ≈ $29.81 Million |
CN¥88.44 Million ≈ $12.94 Million |
0.434x | -- |
About Guangzhou Kingmed Diagnostics Group Co Ltd
Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. It also provides health check-up, cold chain logistics, and other services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.